ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma

Oncogene

Volumn 24, Issue 46, 2005, Pages 6936-6944

  Suzuki, Atsushi ^a,e   Iida, Shinsuke ^b   Kato Uranishi, Miyuki ^b   Tajima, Emi ^b   Zhan, Fenghuang ^c   Hanamura, Ichiro ^c   Huang, Yongsheng ^c   Ogura, Tsutomu ^a   Takahashi, Satoru ^d   Ueda, Ryuzo ^b   Barlogie, Bart ^c   Shaughnessy Jr , John ^c   Esumi, Hiroyasu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

ARK5; IGF 1; Invasion; Large MAF family; Multiple myeloma

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOPROTEIN; MESSENGER RNA; SOMATOMEDIN A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR MAFB; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL INVASION; COLON CARCINOMA; CONTROLLED STUDY; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAF TRANSCRIPTION FACTORS, LARGE; MULTIPLE MYELOMA; PROTEIN KINASES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 27144560153     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208844     Document Type: Article

References (45)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA. (1996). EMBO J., 15, 6541-6551.
2. Asosingh K. (2003). Verh. K. Acad. Geneeskd. Belg., 65, 127-134.
3. Bergsagel PL and Kuehl WM. (2001). Oncogene, 20, 5611-5622.
4. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B and Shaughnessy Jr J. (2005). Blood, 106, 296-303 [E-pub ahead of print, March 8].
5. Datta SR, Brunet A and Greenberg ME. (1999). Genes Dev., 13, 2905-2927.
6. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J and Dedhar S. (1998). Proc. Natl. Acad. Sci. USA, 95, 11211-11216.
7. Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G and Giustolisi R. (2000). Haematologica, 85, 800-805.
8. Drevs J. (2003). Anticancer Res., 23, 1159-1161.
9. Ferlin M, Noraz N, Hertogh C, Brochier J, Taylor N and Klein B. (2000). Br. J. Haematol., 111, 626-634.
10. Hanamura I, Iida S, Akano Y, Hayami Y, Kato M, Miura K, Harada S, Banno S, Wakita A, Kiyoi H, Naoe T, Shimizu S, Sonta SI, Nitta M, Taniwaki M and Ueda R. (2001). Jpn. J. Cancer Res., 92, 638-644.
11. Hannigan GE, Leung-Hagesteijin C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar S. (1996). Nature, 379, 91-96.
12. Hardie DG and Carling D. (1997). Ear. J. Biochem., 246, 259-273.
13. Hayman SR and Fonseca R. (2001). Curr. Treat. Options Oncol., 2, 205-216.
14. Hedge SP, Kumar A, Kurschner C and Shapiro LH. (1998). Mol. Cell. Biol., 18, 2729-2737.
15. Hideshima T and Anderson KC. (2002). Nat. Rev. Cancer, 2, 927-935.
16. Huang K, Serria MS, Nakabayashi H, Nishi S and Sakai M. (2000). Gene, 242, 419-426.
17. Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM and Staudt LM. (2004). Cancer Cell 5, 191-199.
18. Iida S, Hanamura I, Suzuki T, Kamiyama T, Kato M, Hayami Y, Miura K, Harada S, Tsuboi K, wakita A, Akano Y, Taniwaki M, Nitta M and Ueda R. (2000). Int. J. Hematol., 72, 85-91.
19. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RS and Dalla-Favera R. (1997). Nat. Genet., 17, 226-230.
20. Ishikawa H, Tsuyama N, Abroun S, Liu S, Otsuyama K, Zheng X and Kawano MM. (2003). Leukemia Lymphoma, 44, 1477-1481.
21. Kajihara M, Sone H, Amemiya M, Katoh Y, Isogai M, Shimano H, Yamada N and Takahashi S. (2003). Biochem. Biophys. Res. Commun., 312, 831-842.
22. Kataoka K, Fujiwara KT, Noda M and Nishizawa M. (1994a). Mol. Cell. Biol., 14, 7581-7591.
23. Kataoka K, Noda M and Nishizawa M. (1994b). Mol. Cell. Biol., 14, 700-712.
24. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP and Witters LA. (1999). Trends Biochem. Sci., 24, 22-25.
25. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Katsis F, Van Denderen B, Jennings IG, Iseli T, Michell BJ and Witters LA. (2003). Biochem. Soc. Trans., 31, 162-168.
26. Klein B, Tarte K, Jourdan M, Mathouk K, Moreaux J, Jourdan E, Legouffe E, De Vos J and Rossi JF. (2003). Int. J. Hematol., 78, 106-113.
27. Kusakai G, Suzuki A, Ogura T, Kaminishi M and Esumi H. (2004a). J. Exp. Clin. Cancer Res., 23, 263-268.
28. Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M and Esumi H. (2004b). Am. J. Pathol., 164, 987-995.
29. Motohashi H, Shavit JA, Igarashi K, Yamamoto M and Engel JD. (1997). Nucleic Acids Res., 25, 2953-2959.
30. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J and Dedhar S. (2000). Proc. Natl. Acad. Sci. USA, 97, 3207-3212.
31. Persad S and Dedhar S. (2003). Cancer Metast. Rev., 22, 375-384.
32. Qiang YW, Yao L, Tosato G and Rudikoff S. (2004). Blood, 103, 301-308.
33. Ria R, Roccaro AM, Merchionne F, Vacca A, Dammacco F and Ribatti D. (2003). Leukemia, 17, 1961-1966.
34. Seidl S, Kaufmann H and Drach J. (2003). Lancet Oncol., 4, 557-564.
35. Siegel PM and Massague J. (2003). Nat. Rev. Cancer, 3, 807-821.
36. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T and Esumi H. (2003a). Oncogene, 22, 6177-6182.
37. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF and Esumi H. (2003b). J. Biol. Chem., 278, 48-53.
38. Suzuki A, Kusakai G-I, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, Ochiai A and Esumi H. (2004a). Oncogene, 23, 7067-7075.
39. Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T and Esumi H. (2004b). Mol. Cell. Biol., 24, 3526-3535.
40. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C and Anderson KC. (2003). Cancer Res., 63, 5850-5858.
41. Tian E, Zhan F, Walker R, Rasmussan E, Ma Y, Barlogie B and Shaughnessy J. (2003). N. Engl. J. Med., 349, 2483-2494.
42. Yoshida S, Nakazawa N, Iida S, Hayami Y, Sato S, Wakita A, Shimizu S, Taniwaki M and Ueda R. (1999). Leukemia, 13, 1812-1816.
43. Zhan F, Hanamura I, Anaissie E, Burlington B, Huang Y, Ramussen E, Xu H, Tian E, Santra M, Sawyer J, Zangari M, Lee C, Fassas A, Van Rhee F, Talamo G, Thertulian R, Walker R, Crowley J, Tricot G, Barlogie B and Shaughnessy J. (2004). Blood, 104, 26.
44. Zhan F, Hardin J, Bumm K, Zheng M, Tian E, Sanderson R, Tang Y, Wilson C, Zangari M, Anaissie E, Morris C, Muwalla F, Van Rhee F, Fassas A, Ticot G, Crowley J, Barlogie B and Shaughnessy J. (2002). Blood, 99, 1745-1757.
45. Zhan F, Tian E, Bumm K, Smith R, Barlogie B and Shaughnessy J. (2003). Blood, 101, 1128-1140.